Showing 1 - 8 of 8
Persistent link: https://www.econbiz.de/10000893795
Persistent link: https://www.econbiz.de/10009240051
Persistent link: https://www.econbiz.de/10002227583
Persistent link: https://www.econbiz.de/10001780831
Persistent link: https://www.econbiz.de/10001806412
This paper describes three prototypical systems of therapeutic reference pricing (RP) for pharmaceuticals -- Germany, the Netherlands, and New Zealand -- and examines their effects on the availability of new drugs, reimbursement levels, manufacturer prices and out-of-pocket surcharges to...
Persistent link: https://www.econbiz.de/10012468691
This paper examines the role of regulation and competition in generic markets. Generics offer large potential savings to payers and consumers of pharmaceuticals. Whether the potential savings are realized depends on the extent of generic entry and uptake and the level of generic prices. In the...
Persistent link: https://www.econbiz.de/10012461428
Persistent link: https://www.econbiz.de/10013538464